| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.23B | 103.13B | 101.46B | 97.71B | 89.06B | 79.69B |
| Gross Profit | 24.65B | 25.45B | 25.03B | 24.30B | 21.25B | 18.63B |
| EBITDA | 10.18B | 10.16B | 10.43B | 9.83B | 7.96B | 6.17B |
| Net Income | 5.75B | 6.02B | 6.32B | 5.65B | 4.06B | 2.82B |
Balance Sheet | ||||||
| Total Assets | 98.53B | 104.21B | 103.29B | 98.85B | 94.36B | 87.42B |
| Cash, Cash Equivalents and Short-Term Investments | 26.39B | 26.06B | 23.67B | 24.42B | 28.66B | 27.08B |
| Total Debt | 521.00M | 462.00M | 116.00M | 68.00M | 136.00M | 210.00M |
| Total Liabilities | 23.42B | 27.21B | 28.80B | 27.69B | 28.99B | 25.39B |
| Stockholders Equity | 75.11B | 77.00B | 74.48B | 71.16B | 65.37B | 62.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.07B | 2.33B | -1.14B | 2.27B | 4.00B |
| Operating Cash Flow | 0.00 | 6.86B | 7.10B | 4.44B | 5.38B | 7.22B |
| Investing Cash Flow | 0.00 | 3.51B | -5.44B | -3.96B | -3.76B | -3.46B |
| Financing Cash Flow | 0.00 | -3.55B | -3.04B | -1.41B | -1.12B | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥467.51B | 10.13 | 6.90% | 2.71% | -0.06% | 137.47% | |
77 Outperform | ¥108.33B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
74 Outperform | ¥80.96B | 7.02 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥60.55B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥147.28B | 4.25 | 10.46% | 2.35% | 4.56% | 49.23% | |
66 Neutral | ¥11.09B | 13.29 | ― | 4.20% | -5.73% | 20.76% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |